diagnostics

News

Elderly man talks to younger female nurse beside a Grail screening vehicle

Grail's multi-cancer test fluffs its lines in UK trial

Grail's Galleri blood test for cancer screening missed the mark in the much-anticipated NHS-Galleri trial, wreaking havoc with the firm's share price.

News

Grail multi-cancer test taps into Hims & Hers network

Grail has teamed up with telehealth company Hims & Hers to boost access to its recently filed Galleri blood test for cancer screening.

News

UK start-up Procyon has pancreatic cancer test in its sights

Procyon is hoping to launch a diagnostic test next year that will be able to detect people at risk of pancreatic cancer from a urine sample.

News

ESMO: Grail's data on cancer blood test firms up

Data from a new phase 3 trial of Grail's blood test for multiple cancers show improved efficacy and a lower rate of false alarms than a prior study.

R&D

How are healthy biomarker ranges defined?

What makes a biomarker a biomarker?

R&D

Precision medicine - closing the loop: What happens after th...

We often talk about diagnostics as the gateway to precision medicine. But what happens before and after the test?

Grail's multi-cancer test fluffs its lines in UK trial

Grail multi-cancer test taps into Hims & Hers network

UK start-up Procyon has pancreatic cancer test in its sights

ESMO: Grail's data on cancer blood test firms up

How are healthy biomarker ranges defined?

Precision medicine - closing the loop: What happens after th...

Appeal finds NICE must reconsider Alzheimer's drugs

Using AI-driven synthetic personas to take your insights fur...

diagnostics

Editor's Picks